342 related articles for article (PubMed ID: 21593115)
1. Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans.
Lindgren O; Carr RD; Deacon CF; Holst JJ; Pacini G; Mari A; Ahrén B
J Clin Endocrinol Metab; 2011 Aug; 96(8):2519-24. PubMed ID: 21593115
[TBL] [Abstract][Full Text] [Related]
2. Incretin effect after oral amino acid ingestion in humans.
Lindgren O; Pacini G; Tura A; Holst JJ; Deacon CF; Ahrén B
J Clin Endocrinol Metab; 2015 Mar; 100(3):1172-6. PubMed ID: 25490278
[TBL] [Abstract][Full Text] [Related]
3. Increased Incretin But Not Insulin Response after Oral versus Intravenous Branched Chain Amino Acids.
Gojda J; Straková R; Plíhalová A; Tůma P; Potočková J; Polák J; Anděl M
Ann Nutr Metab; 2017; 70(4):293-302. PubMed ID: 28595189
[TBL] [Abstract][Full Text] [Related]
4. The incretin effect in cats: comparison between oral glucose, lipids, and amino acids.
Gilor C; Graves TK; Gilor S; Ridge TK; Weng HY; Dossin O
Domest Anim Endocrinol; 2011 May; 40(4):205-12. PubMed ID: 21397435
[TBL] [Abstract][Full Text] [Related]
5. Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects.
Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
J Clin Endocrinol Metab; 2012 Apr; 97(4):1363-70. PubMed ID: 22319034
[TBL] [Abstract][Full Text] [Related]
6. Differential Effects of Oral and Intravenous Lipid Administration on Key Molecules Related to Energy Homeostasis.
Vamvini MT; Hamnvik OP; Sahin-Efe A; Gavrieli A; Dincer F; Farr OM; Mantzoros CS
J Clin Endocrinol Metab; 2016 May; 101(5):1989-97. PubMed ID: 26964729
[TBL] [Abstract][Full Text] [Related]
7. Incretin and islet hormonal responses to fat and protein ingestion in healthy men.
Carr RD; Larsen MO; Winzell MS; Jelic K; Lindgren O; Deacon CF; Ahrén B
Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E779-84. PubMed ID: 18612044
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of alimentary insulin secretion despite similar gastric inhibitory peptide (GIP) responses in juvenile obesity.
Heptulla RA; Tamborlane WV; Cavaghan M; Bronson M; Limb C; Ma YZ; Sherwin RS; Caprio S
Pediatr Res; 2000 May; 47(5):628-33. PubMed ID: 10813588
[TBL] [Abstract][Full Text] [Related]
9. The incretin effect does not differ in trained and untrained, young, healthy men.
Lund MT; Dalby S; Hartmann B; Helge J; Holst JJ; Dela F
Acta Physiol (Oxf); 2014 Mar; 210(3):565-72. PubMed ID: 24354574
[TBL] [Abstract][Full Text] [Related]
10. Differential islet and incretin hormone responses in morning versus afternoon after standardized meal in healthy men.
Lindgren O; Mari A; Deacon CF; Carr RD; Winzell MS; Vikman J; Ahrén B
J Clin Endocrinol Metab; 2009 Aug; 94(8):2887-92. PubMed ID: 19435824
[TBL] [Abstract][Full Text] [Related]
11. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
[TBL] [Abstract][Full Text] [Related]
12. Effects of chronic exposure of clonal β-cells to elevated glucose and free fatty acids on incretin receptor gene expression and secretory responses to GIP and GLP-1.
Pathak V; Vasu S; Flatt PR; Irwin N
Diabetes Obes Metab; 2014 Apr; 16(4):357-65. PubMed ID: 24164718
[TBL] [Abstract][Full Text] [Related]
13. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
[TBL] [Abstract][Full Text] [Related]
14. Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.
Tura A; Bagger JI; Ferrannini E; Holst JJ; Knop FK; Vilsbøll T; Mari A
Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1123-1129. PubMed ID: 29162361
[TBL] [Abstract][Full Text] [Related]
15. Effects of dipeptidyl peptidase IV inhibition on glycemic, gut hormone, triglyceride, energy expenditure, and energy intake responses to fat in healthy males.
Heruc GA; Horowitz M; Deacon CF; Feinle-Bisset C; Rayner CK; Luscombe-Marsh N; Little TJ
Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E830-7. PubMed ID: 25231186
[TBL] [Abstract][Full Text] [Related]
16. Patients With Long-QT Syndrome Caused by Impaired
Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
[TBL] [Abstract][Full Text] [Related]
17. Effects of variations in duodenal glucose load on glycaemic, insulin, and incretin responses in type 2 diabetes.
Ma J; Pilichiewicz AN; Feinle-Bisset C; Wishart JM; Jones KL; Horowitz M; Rayner CK
Diabet Med; 2012 May; 29(5):604-8. PubMed ID: 22004512
[TBL] [Abstract][Full Text] [Related]
18. Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men.
Carr RD; Larsen MO; Jelic K; Lindgren O; Vikman J; Holst JJ; Deacon CF; Ahrén B
J Clin Endocrinol Metab; 2010 Feb; 95(2):872-8. PubMed ID: 20008019
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of incretin secretion by dietary lipid: is it dose dependent?
Yoder SM; Yang Q; Kindel TL; Tso P
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G299-305. PubMed ID: 19520739
[TBL] [Abstract][Full Text] [Related]
20. Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men.
Matikainen N; Björnson E; Söderlund S; Borén C; Eliasson B; Pietiläinen KH; Bogl LH; Hakkarainen A; Lundbom N; Rivellese A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR
PLoS One; 2016; 11(1):e0145890. PubMed ID: 26752550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
